Literature DB >> 25607835

Role reversal: infiltrating T cells protect the brain.

Lawrence Steinman.   

Abstract

Inflammatory conditions intensify and then resolve, often sparing and recovering some of the injured tissue. While the ebb and flow of inflammation can be followed in many tissues, there is not a great deal of information on how inflammation regresses in the brain. In this issue of the JCI, Walsh, Hendrix, and colleagues illuminate a cellular mechanism whereby T cells that infiltrate the brain after nerve crush or contusion actually protect neurons from injury. These infiltrating T cells produce IL-4 and do so independently of a classic adaptive T cell immune response. The T cells respond to mediators produced by damaged neurons, without the classic three-way interaction among antigen, the major histocompatibility complex, and the T cell receptor. After brain injury, these protective T cells produce IL-4, which attenuates damage via IL-4 receptors on neurons.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25607835      PMCID: PMC4319430          DOI: 10.1172/JCI80279

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  Interleukin 10 modulation of pathogenic Th17 cells during fatal alphavirus encephalomyelitis.

Authors:  Kirsten A Kulcsar; Victoria K Baxter; Ivorlyne P Greene; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-31       Impact factor: 11.205

2.  Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

Authors:  T A Yednock; C Cannon; L C Fritz; F Sanchez-Madrid; L Steinman; N Karin
Journal:  Nature       Date:  1992-03-05       Impact factor: 49.962

Review 3.  A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya).

Authors:  Jerold Chun; Volker Brinkmann
Journal:  Discov Med       Date:  2011-09       Impact factor: 2.970

4.  Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein.

Authors:  S Brocke; K Gijbels; M Allegretta; I Ferber; C Piercy; T Blankenstein; R Martin; U Utz; N Karin; D Mitchell; T Veromaa; A Waisman; A Gaur; P Conlon; N Ling; P J Fairchild; D C Wraith; A O'Garra; C G Fathman; L Steinman
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

5.  Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease.

Authors:  E Hauben; E Agranov; A Gothilf; U Nevo; A Cohen; I Smirnov; L Steinman; M Schwartz
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 6.  Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation.

Authors:  Timothy Hla; Volker Brinkmann
Journal:  Neurology       Date:  2011-02-22       Impact factor: 9.910

Review 7.  Nuanced roles of cytokines in three major human brain disorders.

Authors:  Lawrence Steinman
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

Review 8.  How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis.

Authors:  Lawrence Steinman; Scott S Zamvil
Journal:  Ann Neurol       Date:  2006-07       Impact factor: 10.422

9.  OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS.

Authors:  T M Rivers; D H Sprunt; G P Berry
Journal:  J Exp Med       Date:  1933-06-30       Impact factor: 14.307

10.  The discovery of natalizumab, a potent therapeutic for multiple sclerosis.

Authors:  Lawrence Steinman
Journal:  J Cell Biol       Date:  2012-10-29       Impact factor: 10.539

View more
  1 in total

1.  Reciprocal Interplay Between Astrocytes and CD4+ Cells Affects Blood-Brain Barrier and Neuronal Function in Response to β Amyloid.

Authors:  Simona Federica Spampinato; Sara Merlo; Evelina Fagone; Mary Fruciano; Yasuteru Sano; Takashi Kanda; Maria Angela Sortino
Journal:  Front Mol Neurosci       Date:  2020-07-03       Impact factor: 5.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.